Abstract
The HOX11/TLX1 homeobox gene is aberrantly expressed in a subset of T-cell acute lymphoblastic leukemia (T-ALL). Here, we employed oligonucleotide microarrays to compare the expression profiles of the K3P and Sil leukemic cell lines originating from patients with HOX11+ T-ALL to that of Jurkat cells, which originated from a distinct subtype of T-ALL (TAL1+). To distinguish potential HOX11 target genes from those characteristic of the stage of HOX11 leukemic arrest, we also performed gene expression analysis on Jurkat cells, genetically engineered to express exogenous HOX11. The resulting HOX11 gene expression signature, which was validated for representative signaling pathways by transient transfection of reporter constructs, was characterized by elevated expression of transcriptional programs involved in cell proliferation, including those regulated by E2F, c-Myc and cAMP response element-binding protein. We subsequently showed that ectopic HOX11 expression resulted in hyperphosphorylation of the retinoblastoma protein (Rb), which correlated with inhibition of the major Rb serine/threonine phosphatase PP1. HOX11 also inhibited PP2A serine/threonine phosphatase activity concomitant with stimulation of the AKT/PKB signaling cascade. These results suggest that transcriptional deregulation of G1/S growth-control genes, mediated in large part through blockade of PP1/PP2A phosphatase activity, plays an important role in HOX11 pathobiology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adler HT, Nallaseth FS, Walter G and Tkachuk DC . (1997). J. Biol. Chem., 272, 28407–28414.
Agata Y, Katakai T, Ye SK, Sugai M, Gonda H, Honjo T, Ikuta K and Shimizu A . (2001). J. Exp. Med., 193, 873–880.
Ait-Si-Ali S, Ramirez S, Barre FX, Dkhissi F, Magnaghi-Jaulin L, Girault JA, Robin P, Knibiehler M, Pritchard LL, Ducommun B, Trouche D and Harel-Bellan A . (1998). Nature, 396, 184–186.
Alberts AS, Montminy M, Shenolikar S and Feramisco JR . (1994). Mol. Cell Biol., 14, 4398–4407.
Allen TD, Zhu Y-X, Hawley TS and Hawley RG . (2000). Leuk. Lymphoma, 39, 241–256.
Ambach A, Saunus J, Konstandin M, Wesselborg S, Meuer SC and Samstag Y . (2000). Eur. J. Immunol., 30, 3422–3431.
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM and Sherlock G . (2000). Nat. Genet., 25, 25–29.
Avni D, Yang H, Martelli F, Hofmann F, ElShamy WM, Ganesan S, Scully R and Livingston DM . (2003). Mol. Cell, 12, 735–746.
Baudino TA, Maclean KH, Brennan J, Parganas E, Yang C, Aslanian A, Lees JA, Sherr CJ, Roussel MF and Cleveland JL . (2003). Mol. Cell, 11, 905–914.
Beijersbergen RL, Hijmans EM, Zhu L and Bernards R . (1994). EMBO J., 13, 4080–4086.
Berndt N, Dohadwala M and Liu CW . (1997). Curr. Biol., 7, 375–386.
Blobel GA . (2000). Blood, 95, 745–755.
Brennan P, Babbage JW, Burgering BM, Groner B, Reif K and Cantrell DA . (1997). Immunity, 7, 679–689.
Canettieri G, Morantte I, Guzman E, Asahara H, Herzig S, Anderson SD, Yates III JR and Montminy M . (2003). Nat. Struct. Biol., 10, 175–181.
Chen Q, Lin J, Jinno S and Okayama H . (2003). Oncogene, 22, 992–1001.
Chen W, Possemato R, Campbell KT, Plattner CA, Pallas DC and Hahn WC . (2004). Cancer Cell, 5, 127–136.
Cicchillitti L, Fasanaro P, Biglioli P, Capogrossi MC and Martelli F . (2003). J. Biol. Chem., 278, 19509–19517.
Ciofani M, Schmitt TM, Ciofani A, Michie AM, Cuburu N, Aublin A, Maryanski JL and Zuniga-Pflucker JC . (2004). J. Immunol., 172, 5230–5239.
Classon M and Harlow E . (2002). Nat. Rev. Cancer., 2, 910–917.
Cohen PT . (2002). J. Cell Sci., 115, 241–256.
Conkright MD, Guzman E, Flechner L, Su AI, Hogenesch JB and Montminy M . (2003). Mol. Cell, 11, 1101–1108.
Dear TN, Sanchez-Garcia I and Rabbitts TH . (1993). Proc. Natl. Acad. Sci. USA, 90, 4431–4435.
Dominguez-Caceres MA, Garcia-Martinez JM, Calcabrini A, Gonzalez L, Porque PG, Leon J and Martin-Perez J . (2004). Oncogene, 23, 7378–7390.
Du J and Hannon GJ . (2002). Nucleic. Acids. Res., 30, 5465–5475.
Dube ID, Kamel-Reid S, Yuan CC, Lu M, Wu X, Corpus G, Raimondi SC, Crist WM, Carroll AJ, Minowada J and Baker JB . (1991). Blood, 78, 2996–3003.
Ebert BL and Golub TR . (2004). Blood, 104, 923–932.
Eckner R, Ludlow JW, Lill NL, Oldread E, Arany Z, Modjtahedi N, DeCaprio JA, Livingston DM and Morgan JA . (1996). Mol. Cell Biol., 16, 3454–3464.
Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A and Amati B . (2003). Genes Dev., 17, 1115–1129.
Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, Behm FG, Pui CH, Downing JR, Gilliland DG, Lander ES, Golub TR and Look AT . (2002). Cancer Cell, 1, 75–87.
Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM, Livingston DM and Amati B . (2003). EMBO Rep., 4, 575–580.
Franke TF, Kaplan DR, Cantley LC and Toker A . (1997). Science, 275, 665–668.
Freeburn RW, Wright KL, Burgess SJ, Astoul E, Cantrell DA and Ward SG . (2002). J. Immunol., 169, 5441–5450.
Fry CJ, Pearson A, Malinowski E, Bartley SM, Greenblatt J and Farnham PJ . (1999). J. Biol. Chem., 274, 15883–15891.
Fujimoto M, Naka T, Nakagawa R, Kawazoe Y, Morita Y, Tateishi A, Okumura K, Narazaki M and Kishimoto T . (2000). J. Immunol., 165, 1799–1806.
Galasinski SC, Resing KA, Goodrich JA and Ahn NG . (2002). J. Biol. Chem., 277, 19618–19626.
Gat U, DasGupta R, Degenstein L and Fuchs E . (1998). Cell, 95, 605–614.
Goodman RH and Smolik S . (2000). Genes Dev., 14, 1553–1577.
Gounari F, Aifantis I, Khazaie K, Hoeflinger S, Harada N, Taketo MM and von BH . (2001). Nat. Immunol., 2, 863–869.
Grady GC, Mason SM, Stephen J, Zuniga-Pflucker JC and Michie AM . (2004). J. Immunol., 173, 1802–1810.
Greene WK, Bahn S, Masson N and Rabbitts TH . (1998). Mol. Cell Biol., 18, 7030–7037.
Hatano M, Roberts CW, Minden M, Crist WM and Korsmeyer SJ . (1991). Science, 253, 79–82.
Hateboer G, Wobst A, Petersen BO, Le CL, Vigo E, Sardet C and Helin K . (1998). Mol. Cell Biol., 18, 6679–6697.
Hawley RG, Fong AZC, Lu M and Hawley TS . (1994a). Oncogene, 9, 1–12.
Hawley RG, Fong AZC, Ngan B-Y and Hawley TS . (1995). Oncogene, 11, 1113–1123.
Hawley RG, Fong AZC, Reis MD, Zhang N, Lu M and Hawley TS . (1997). Cancer Res., 57, 337–345.
Hawley RG, Lieu FHL, Fong AZC and Hawley TS . (1994b). Gene Ther., 1, 136–138.
Ioannidis V, Beermann F, Clevers H and Held W . (2001). Nat. Immunol., 2, 691–697.
Ishitani T, Ninomiya-Tsuji J and Matsumoto K . (2003). Mol. Cell. Biol., 23, 1379–1389.
Ivaska J, Nissinen L, Immonen N, Eriksson JE, Kahari VM and Heino J . (2002). Mol. Cell. Biol., 22, 1352–1359.
Janssens V and Goris J . (2001). Biochem. J., 353, 417–439.
Kang-Decker N, Tong C, Boussouar F, Baker DJ, Xu W, Leontovich AA, Taylor WR, Brindle PK and van Deursen JM . (2004). Cancer Cell, 5, 177–189.
Karsunky H, Mende I, Schmidt T and Moroy T . (2002). Oncogene, 21, 1571–1579.
Kawabe T, Muslin AJ and Korsmeyer SJ . (1997). Nature, 385, 454–458.
Keller G, Wall C, Fong AZC, Hawley TS and Hawley RG . (1998). Blood, 92, 877–887.
Kelly DP and Scarpulla RC . (2004). Genes Dev., 18, 357–368.
Krasnoselskaya-Riz I, Spruill A, Chen YW, Schuster D, Teslovich T, Baker C, Kumar A and Stephan DA . (2002). AIDS Res. Hum. Retroviruses, 18, 591–604.
Kutney SN, Hong R, Macfarlan T and Chakravarti D . (2004). J. Biol. Chem., 279, 30850–30855.
Li M, Makkinje A and Damuni Z . (1996). J. Biol. Chem., 271, 11059–11062.
Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ and Ren B . (2003). Proc. Natl. Acad. Sci. USA, 100, 8164–8169.
Ludlow JW and Nelson DA . (1995). Semin. Cancer Biol., 6, 195–202.
Luo Q, Li J, Cenkci B and Kretzner L . (2004). Oncogene, 23, 1088–1097.
Luo RX, Postigo AA and Dean DC . (1998). Cell, 92, 463–473.
Ma Y, Yuan J, Huang M, Jove R and Cress WD . (2003). J. Biol. Chem., 278, 16770–16776.
Mathieu N, Hempel WM, Spicuglia S, Verthuy C and Ferrier P . (2000). J. Exp. Med., 192, 625–636.
Owens BM and Hawley RG . (2002). Stem. Cells, 20, 364–379.
Owens BM, Hawley RG and Spain LM . (2004). Methods Mol. Med., 105, 311–322.
Owens BM, Zhu YX, Suen TC, Wang PX, Greenblatt JF, Goss PE and Hawley RG . (2003). Blood, 101, 4966–4974.
Pallas DC, Shahrik LK, Martin BL, Jaspers S, Miller TB, Brautigan DL and Roberts TM . (1990). Cell, 60, 167–176.
Pulford K, Lecointe N, Leroy-Viard K, Jones M, Mathieu-Mahul D and Mason DY . (1995). Blood, 85, 675–684.
Ramezani A, Hawley TS and Hawley RG . (2003). Blood, 101, 4717–4724.
Ratcliffe MJ, Itoh K and Sokol SY . (2000). J. Biol. Chem., 275, 35680–35683.
Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA and Dynlacht BD . (2002). Genes Dev., 16, 245–256.
Riz I, Eaker S and Hawley RG . (2003). Appl. Genomics Proteomics, 1, 95–108.
Rudenko A, Bennett D and Alphey L . (2003). EMBO Rep., 4, 59–63.
Schmidt T, Karsunky H, Gau E, Zevnik B, Elsasser HP and Moroy T . (1998a). Oncogene, 17, 2661–2667.
Schmidt T, Karsunky H, Rodel B, Zevnik B, Elsasser HP and Moroy T . (1998b). EMBO J., 17, 5349–5359.
Schneider R, Bannister AJ, Weise C and Kouzarides T . (2004). J. Biol. Chem., 279, 23859–23862.
Sears RC and Nevins JR . (2002). J. Biol. Chem., 277, 11617–11620.
Shan X, Czar MJ, Bunnell SC, Liu P, Liu Y, Schwartzberg PL and Wange RL . (2000). Mol. Cell Biol, 20, 6945–6957.
Shen WF, Krishnan K, Lawrence HJ and Largman C . (2001). Mol. Cell Biol., 21, 7509–7522.
Sonoki T, Harder L, Horsman DE, Karran L, Taniguchi I, Willis TG, Gesk S, Steinemann D, Zucca E, Schlegelberger B, Sole F, Mungall AJ, Gascoyne RD, Siebert R and Dyer MJ . (2001). Blood, 98, 2837–2844.
Sontag E, Sontag JM and Garcia A . (1997). EMBO J., 16, 5662–5671.
Tan PK, Downey TJ, Spitznagel Jr EL, Xu P, Fu D, Dimitrov DS, Lempicki RA, Raaka BM and Cam MC . (2003). Nucleic. Acids. Res., 31, 5676–5684.
Taubert S, Gorrini C, Frank SR, Parisi T, Fuchs M, Chan HM, Livingston DM and Amati B . (2004). Mol. Cell Biol., 24, 4546–4556.
Trop S, De SP, Zuniga-Pflucker JC and Rottapel R . (2001). Blood, 97, 2269–2277.
Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H and Hillen W . (2000). Proc. Natl. Acad. Sci. USA, 97, 7963–7968.
Varas A, Hager-Theodorides AL, Sacedon R, Vicente A, Zapata AG and Crompton T . (2003). Trends. Immunol., 24, 197–206.
Verbeek S, Izon D, Hofhuis F, Robanus-Maandag E, te RH, van de WM, Oosterwegel M, Wilson A, MacDonald HR and Clevers H . (1995). Nature, 374, 70–74.
von Lindern M, van BS, Wiegant J, Raap A, Hagemeijer A and Grosveld G . (1992). Mol. Cell. Biol., 12, 3346–3355.
Voorhoeve PM, Hijmans EM and Bernards R . (1999). Oncogene, 18, 515–524.
Wadzinski BE, Wheat WH, Jaspers S, Peruski Jr LF, Lickteig RL, Johnson GL and Klemm DJ . (1993). Mol. Cell. Biol., 13, 2822–2834.
Wang JM, Chao JR, Chen W, Kuo ML, Yen JJ and Yang-Yen HF . (1999). Mol. Cell. Biol., 19, 6195–6206.
Weaver BK, Kumar KP and Reich NC . (1998). Mol. Cell. Biol., 18, 1359–1368.
Weinmann AS, Yan PS, Oberley MJ, Huang TH and Farnham PJ . (2002). Genes Dev., 16, 235–244.
Wells J, Graveel CR, Bartley SM, Madore SJ and Farnham PJ . (2002). Proc. Natl. Acad. Sci. USA, 99, 3890–3895.
Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT and Aster JC . (2004). Science, 306, 269–271.
Yalcin A, Koulich E, Mohamed S, Liu L and D'Mello SR . (2003). J. Neurochem., 84, 397–408.
Yan Y and Mumby MC . (1999). J. Biol. Chem., 274, 31917–31924.
Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, Counter CM, Nevins JR, Means AR and Sears R . (2004). Nat. Cell. Biol., 6, 308–318.
Yu WM, Hawley TS, Hawley RG and Qu CK . (2003). Oncogene, 22, 5995–6004.
Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA and Dang CV . (2003). Genome. Biol., 4, R69.
Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW and Dean DC . (2000). Cell, 101, 79–89.
Acknowledgements
We gratefully acknowledge Vladimir Kuznetsov for statistical analysis support and Timothy McCaffrey for advice on GeneSpring software. We also thank Wen-mei Yu for technical assistance during part of this work and help with data presentation, Joseph Molete and Teresa Hawley for providing NIH3T3/iHOX11 cells, and Ali Ramezani for the gift of the β-catenin lentiviral vector. This work was supported in part by National Institutes of Health grants R01HL65519, R01HL66305 and R24RR16209.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)
Supplementary information
Supplementary Information
Supplementary Information (PDF 73 kb)
Supplementary Figure 1
Supplementary Figure 1 (PDF 306 kb)
Rights and permissions
About this article
Cite this article
Riz, I., Hawley, R. G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia. Oncogene 24, 5561–5575 (2005). https://doi.org/10.1038/sj.onc.1208727
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208727
Keywords
This article is cited by
-
Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression
Cellular Oncology (2018)
-
Correlation Between Meis1 and Msi1 in Esophageal Squamous Cell Carcinoma
Journal of Gastrointestinal Cancer (2016)
-
NKL homeobox genes in leukemia
Leukemia (2012)
-
TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells
Molecular Cancer (2010)
-
Phosphorylation of HOX11/TLX1 on Threonine-247 during mitosis modulates expression of cyclin B1
Molecular Cancer (2010)